Steven J Greco

About Steven J Greco

Steven J. Greco, PhD, of Pinehurst, TX, is a leading figure in the field of regenerative medicine. As the Founder and Chief Operating Officer of PranaX Corporation, a Houston-based biomedical research and applications company, he has demonstrated his expertise in life sciences. His study of biological science at Cornell University, along with his doctoral work in biomedical science with a concentration in stem cell biology at Rutgers, has paved the way for his impressive success in leveraging the biology of exosomes to drive specific regenerative processes in humans. His knowledge of how the processing and development of certain chemicals can reverse damaged or inflamed tissue and organs, which can, in turn, slow down age-related decline in appearance and improve the quality of health in later years, is particularly notable.

Greco’s work with many early-stage biotech companies gave him critical experiences in multiple aspects of drug development and inspired his interest in stem cell biology and regenerative processes. He was the Co-founder of Rejenevie Therapeutics and the Chief Scientific Officer for Houston Healthspan Innovation Group, both of which are regenerative medicine companies acquired to serve as subsidiaries of PranaX, which he launched in 2022. PranaX serves as a vehicle in which Greco leverages his professional knowledge and university research on Alzheimer’s disease and other complications of aging to develop several in vitro diagnostics and biomarker identification processes.

Over the past 2 decades, Steven has been unwavering in his commitment to research and training as a stem cell biologist. His contributions to regenerative and translational medicine, a scientific field that translates scientific discoveries from the lab into clinical practice and therapeutic applications, are numerous. Greco’s passion for teaching the next generation of scientists the latest theories and practices of rejuvenation medicine is evident through the Stem Cell Education Society, which he founded to raise public awareness about stem cell applications and give presentations to students, scientists, and colleagues.